UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                Washington, D.C.  20549
                     Form 10-Q

           UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549
                               Form 10-Q


X     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE 
---      SECURITIES SECURITIES EXCHANGE ACT OF 1934


      For the quarterly period ended March 31, 1998
                                     -----------------

                                             or

      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
---   SECURITIES EXCHANGE ACT OF 1934

      For the transition period from         to

      Commission file number   1-07151

                               -------


                    THE CLOROX COMPANY
---------------------------------------------------------------
(Exact name of registrant as specified in its charter) 



        DELAWARE                             31-0595760        
---------------------------------------------------------------
(State or other jurisdiction of         (I.R.S. Employer  
incorporation or organization)          Identification number) 



1221 Broadway - Oakland, California            94612 - 1888
---------------------------------------------------------------
(Address of principal executive offices)


Registrant's telephone number,               (510)-271-7000    
(including area code)                                          


---------------------------------------------------------------
(Former name, former address and former fiscal year,
          if changed since last report)



(Former name, former address and former fiscal year, if changed 
since last report)  Indicate by check mark whether the registrant  
(1)  has filed all report required to be filed by Section 13 or 
15(d) of the Securities Exchange Act of 1934 during the preceding 
12 months (or for such shorter period that the registrant was 
required to file such reports), and  (2)  has been subject to such 
filing requirements for the past 90 days. 
                                                        
          Yes         X           No                               
                                                            
                                                     
As of March 31, 1998 there were 103,881,950 shares outstanding of the 
registrant's common stock  (par-value -  $1.00), the registrant's 
only outstanding class of stock.                                  

                                                   Total  pages 10 
                                                                 1

                       THE CLOROX COMPANY                          
                                                 
PART 1.   Financial Information                        Page No. 
          ---------------------                        --------
                    
          Item 1. Financial Statements           
                         
                  Condensed Statements of 
                   Consolidated Earnings                
                    Three and Nine Months Ended 
                    March 31, 1998 and 1997                3 
                          
                          
                  Condensed Consolidated Balance Sheets  
                    March 31, 1998 and June 30, 1997       4 
                          
                         
                  Condensed Statements of Consolidated 
                   Cash Flows            
                    Nine Months Ended March 31, 1998 
                          and 1997                         5 
                          
                         
                  Notes to Condensed Consolidated 
                   Financial Statements                   6-7 
                         
                         
          Item 2. Management's Discussion and 
                   Analysis of Results of Operations 
                   and Financial Condition                8-10 

<PAGE>
<TABLE>
<CAPTION>


                                       PART I - FINANCIAL INFORMATION
                                        Item 1. Financial Statements
                                     The Clorox Company and Subsidiaries
                                Condensed Statements of Consolidated Earnings
                                ---------------------------------------------
                                  (In thousands, except per-share amounts)


                                       Three Months Ended                       Nine Months Ended
                              ---------------------------------           --------------------------------
                                 3/31/98                3/31/97              3/31/98                3/31/97
                              ----------            -----------           ----------             ----------
<S>                           <C>                   <C>                   <C>                    <C>  
Net Sales                     $  680,540            $   649,209           $1,921,619             $1,770,197
                              ----------            -----------           ----------             ----------

Costs and Expenses                                                                               
  Cost of products sold          290,209                287,862              828,092                780,849 

  Selling, delivery and 
   administration                142,378                135,355              412,566                372,388 
                                                                                
  Advertising                     93,856                 84,543              268,808                254,427 
                                                                                
  Research and development        13,573                 12,035               38,186                 34,065 
                                                                                
  Interest expense                15,438                 17,005               50,346                 39,247 

  Other expense (income), net        693                  2,603               (3,797)                (2,356) 
                              ----------            -----------           ----------             ----------
  Total costs and expenses       556,147                539,403            1,594,201              1,478,620 
                              ----------            -----------           ----------             ----------

Earnings before Income Taxes     124,393                109,806              327,418                291,577 
                                                                                
Income Taxes                      48,444                 44,186              127,623                116,532 
                              ----------            -----------           ----------             ----------
                                                                               
Net Earnings                  $   75,949            $    65,620           $  199,795             $  175,045 
                              ==========            ===========           ==========             ==========
                                                                              
                                 
Earnings per Common Share                                                                            
  Basic                       $     0.73            $      0.63           $     1.93             $     1.69 
  Diluted                           0.72                   0.62                 1.89                   1.66 
                                                                              
                                                                           
Weighted Average Shares
 Outstanding                                                                            
   Basic                         103,704                 103,480              103,438               103,314 
   Diluted                       105,779                 105,296              105,743               105,340 
                                                                                    
                                                                            
Dividends per Share           $     0.32             $      0.29           $     0.96            $     0.87 


See Notes to Condensed Consolidated Financial Statements.                                                  
</TABLE>

<PAGE>
<TABLE>
<CAPTION>

                                       PART I - FINANCIAL INFORMATION
                                        Item 1. Financial Statements
                                     The Clorox Company and Subsidiaries
                                   Condensed Consolidated Balance Sheets
                                   -------------------------------------
                                                (In thousands)

                                                               3/31/98                6/30/97      
                                                             -----------            -----------
<S>                                                          <C>                    <C>
ASSETS                                              
------
  Current Assets                                         
    Cash and short-term investments                          $    75,499            $   101,046 
        Accounts receivable, net                                 446,416                356,996 
        Inventories                                              237,182                170,340 
        Prepaid expenses                                          40,752                 22,534 
        Deferred income taxes                                     18,418                 22,581 
                                                             -----------            -----------
        Total current assets                                      18,267                673,497 
                                                  
    Property, Plant and Equipment - Net                          570,276                570,645 
                                                  
    Brands, Trademarks, Patents and Other Intangibles          1,219,137              1,186,951 
                                                      
    Investments in Affiliates                                     89,096                 93,004 
                                                  
    Other Assets                                                 279,128                253,855 
                                                             -----------            -----------
                                                  
     Total                                                   $ 2,975,904            $ 2,777,952 
                                                             ===========            ===========
                                                  
LIABILITIES AND STOCKHOLDERS' EQUITY                                                   
  Current Liabilities                                              
    Accounts payable                                         $   131,816            $   143,360 
    Accrued liabilities                                          250,089                358,785 
    Short-term debt                                              462,178                369,973 
    Income taxes payable                                          37,417                 17,049 
    Current maturities of long-term debt                              45                  3,551 
                                                             -----------            -----------
   Total current liabilities                                     881,545                892,718 
                                                  
   Long-term Debt                                                703,586                565,926 
                                              
   Other Obligations                                             124,162                112,539 
                                                  
   Deferred Income Taxes                                         166,343                170,723 
                                              
   Share Repurchase Obligations                                   54,848                   -  
                                             
   Stockholders' Equity                                              
     Common stock                                                110,845                110,844 
     Additional paid-in capital                                   80,557                 66,803 
     Retained earnings                                         1,315,089              1,207,524 
     Treasury shares, at cost                                   (363,608)              (289,075) 
     Cumulative translation adjustments and other                (97,463)               (60,050) 
                                                             -----------            -----------
       Stockholders' Equity                                    1,045,420              1,036,046 
                                                             -----------            -----------

     Total                                                   $ 2,975,904            $ 2,777,952 


See Notes to Condensed Consolidated Financial Statements.                                      4 

</TABLE>

<PAGE>
<TABLE>
<CAPTION>


                             PART I - FINANCIAL INFORMATION (Continued)
                                  Item 1.  Financial Statements
                               The Clorox Company and Subsidiaries
                           Condensed Statements of Consolidated Cash Flows
                           -----------------------------------------------
                                             (In thousands)
                                                                                Nine Months Ended
                                                                       ------------------------------------
                                                                          3/31/98                3/31/97   
                                                                       -------------          -------------
<S>                                                                    <C>                    <C>
Operations:                                              
  Net earnings                                                         $     199,795          $     175,045
  Adjustments to reconcile to net cash provided by operating activities:
    Depreciation and amortization                                             95,912                 92,312 
    Deferred income taxes                                                     22,653                  4,351 
    Other                                                                    (10,291)                (2,639) 
    Effects of changes in:                                       
      Accounts  receivable                                                   (84,871)               (55,297) 
      Inventories                                                            (64,944)               (53,079) 
      Prepaid expenses                                                         6,923                 (1,250) 
      Accounts payable                                                       (13,430)               (25,875) 
      Accrued liabilities                                                    (90,106)                 6,635 
      Income taxes payable                                                    14,547                 19,311 
                                                                       -------------          -------------
                                         
      Net cash provided by operations                                         76,188                159,514 
                                               


Investing Activities:                                                 
  Property, plant and equipment                                              (56,539)               (56,196) 
  Disposal of property, plant and equipment                                    3,567                  1,764 
  Businesses purchased                                                      (107,777)              (460,336) 
  Other                                                                      (40,885)               (59,830) 
                                                                       -------------          -------------
                                  
    Net cash used for investment                                            (201,634)              (574,598) 
                                                                       -------------          -------------
                                                
Financing Activities:                                                
  Short-term borrowing                                                       13,407                     -     
  Short-term debt repayments                                               (161,719)                    -    
  Long-term borrowings                                                      193,736                 526,656 
  Long-term debt and other obligations  repayments                          (61,549)                (14,981) 
  Commercial paper, net                                                     238,078                  22,003 
  Cash dividends                                                            (99,149)                (89,967) 
  Treasury stock purchased                                                  (47,380)                (35,459) 
  Employee stock plans and other                                             24,475                  29,736 
                                                                       ------------            -------------
                                                
    Net cash provided by financing                                           99,899                 437,988 
                                                                       ------------            -------------
                                                
Net (Decrease) Increase in Cash and Short-Term Investments                  (25,547)                 22,904 
Cash and Short-Term Investments:                                                 
     Beginning of period                                                    101,046                  90,828 
                                                
     End of period                                                     $     75,499            $    113,732 
                                                                       ============            =============
                                              
                                              
See Notes to Condensed Consolidated Financial Statements                                             5

</TABLE>

                                               
         PART I - FINANCIAL INFORMATION (Continued)
              Item 1.  Financial Statements
            The Clorox Company and Subsidiaries
    Notes to Condensed Consolidated Financial Statements


(1)  The summarized financial information for the three and nine 
months ended March 31, 1998 and 1997 has not been audited but, 
in the opinion of management, includes all adjustments 
(consisting only of normal recurring accruals) necessary for a 
fair presentation of the results of operations, financial 
position, and cash flows of The Clorox Company and its subsidiaries 
(the "Company").  The results of the three and nine months ended 
March 31, 1998 and 1997 should not be considered as necessarily 
indicative of the results for the entire year.


(2)  Inventories at March 31, 1998 and at June 30, 1997 consisted 
of (in thousands):

                                      3/31/98           6/30/97
                                    ---------         ---------
Finished goods and work in process  $ 158,698         $ 109,189
Raw materials and supplies             78,484            61,151
             
     Total                          $ 237,182         $ 170,340


(3)  International businesses purchased for the nine months 
ended March 31, 1998 totaling $107,777,000 were funded using a 
combination of cash and long-term borrowings and were accounted 
for as purchases.  These acquisitions included an additional 
investment in Mexico, the Clorosul bleach business and the Super 
Globo bleach and cleaner businesses in Brazil and two smaller 
acquisitions in Southeast Asia and Australia.
     
     Acquisitions for the nine months ended March  31, 1997 totaled 
$460,336,000 and included the Armor All Products Corporation for 
$360,144,000.  The acquisition occurred on December 31, 1996.  
Other businesses purchased included the Shell Group's non-core 
line of household products in Chile, the Pinoluz brand of pine 
cleaner in Argentina, and the Limpido brand of liquid bleach and 
an increase in ownership in Tecnoclor, S.A. both in Colombia.  
These acquisitions were accounted for as purchases and were 
funded from cash provided by operations, long-term borrowings 
and commercial paper. 


(4)     The Company entered into two share repurchase transactions 
during the second quarter of fiscal 1998 whereby Clorox contracted 
for the future delivery of 400,000 shares of Clorox stock on 
October 27, 2000 and 400,000 shares of Clorox stock on October 23, 
2002.  The specified strike prices are $68.50 and $68.62 per share.  
The aggregate redemption cost of $54,848,000 has been classified as 
share repurchase obligations with a corresponding increase in 
treasury stock.  The Company paid a premium of $13,193,000 on 
this transaction which has been recorded as treasury stock and 
at maturity will become part of the basis in the repurchased shares.
     
(5)  Impact of New Accounting Standard
     
     In February 1997, the Financial Accounting Standards Board 
issued Statement of Financial Accounting Standards No. 128 
("SFAS 128"), Earnings per Share.  SFAS 128 requires dual 
presentation of basic EPS and diluted EPS on the face of all 
earnings statements issued after December 15, 1997 for all 
entities with complex capital structures.  Basic earnings per 
share is computed by dividing net earnings by the weighted 
average number of common shares outstanding each period.  
Diluted earnings per share are computed by dividing net earnings 
by the diluted weighted average number of common shares 
outstanding during the period.  Diluted EPS reflects the potential 
dilution that could occur from common shares issuable through 
stock options, restricted stock, warrants and other convertible 
securities.  The weighted average number of shares outstanding 
(denominator) used to calculate basic earnings per share is 
reconciled to those used in calculating diluted earnings per 
share as follows:


<TABLE>
<CAPTION>

                                               Weighted Average Number
                                                of Shares Outstanding
                          ----------------------------------------------------------------
                             Three Months Ended                     Nine Months Ended
                          -------------------------              -------------------------
                          3/31/98           3/31/97              3/31/98           3/31/97
                          -------           -------              -------           -------
<S>                       <C>               <C>                  <C>               <C>
Basic                     103,704           103,480              103,438           103,314
                                                         
Stock options               2,027             1,790               2,257              2,000
                                                         
Other                          48                26                  48                 26
                          -------           -------              -------           -------
                              
Diluted                   105,779           105,296              105,743           105,340
                          =======           =======              =======           ======= 
</TABLE>

(6)  Stock Split
     
     On July 15, 1997, the Company's Board of Directors 
authorized a 2-for-1 split of its common stock effective 
September 2, 1997, in the form of a stock dividend for 
stockholders of record at the close of business on July 28, 
1997.  All share and per share amounts in the accompanying 
consolidated financial statements have been restated to give 
effect to the stock split.



      PART I - FINANCIAL INFORMATION (Continued)
    Item 2.  Management's Discussion and Analysis of
      Results of Operations and Financial Condition
      ---------------------------------------------

                Results of Operations
                ---------------------

    Comparison of the Three Months Ended March 31, 1998
    ---------------------------------------------------
        with the Three Months Ended March 31, 1997
        ------------------------------------------

Basic earnings per share increased 16 percent to 73 cents from 
63 cents a year ago and net earnings increased 16 percent to 
$75,949,000 from $65,620,000.  Earnings per share reflect a 
2-for-1 stock split on September 2, 1997.  

Net sales increased 5 percent to $680,540,000 due primarily to 
volume growth.  The 5 percent volume increase was slightly 
lower than the year to date increase due to the inclusion of 
Armor All starting in the third quarter last year and timing 
on shipments in our seasonal business units namely charcoal, 
insecticides and Armor All.  Shipments for these business units 
were affected by promotional timing skewed toward fourth 
quarter results.  

In the U.S., total shipments  were a third quarter record.  
Domestic brands having record shipments and contributing to 
quarterly growth include the Pine-Sol and Tilex franchises, 
KC Masterpiece barbecue sauces, Brita water filtration systems 
and the cat litter unit which includes the combined shipments 
of Fresh Step Scoop and Fresh Step.  These brands also recorded 
strong year to date growth.  Shipments of Clorox bleach 
decreased slightly reflecting a price increase effective in 
October 1997.  Shipments in our international business 
increased 12 percent of which approximately half was from 
base businesses and the remainder from acquisitions.  The 
bleach and cleaner business acquired in Brazil is marketed 
under the brand name of Super Globo.  The Super Globo bleach 
business combined with three other acquisitions announced 
earlier this year provides us with continued expansion outside
the U.S.

Cost of goods sold as a percentage of sales was 42.6 and 44.3 
percent in the current and year ago quarters, respectively.  
The improvement reflects the impact of cost savings initiatives 
throughout the product supply chain, improvement in our Latin 
America businesses, benefits from the consolidation of Armor All,
and some slight price declines in several raw materials.

Advertising expense increased 11 percent principally due to our 
continued investment in the health of our brands as well as 
spending on new product introductions.  We continue to anticipate 
that for the full year advertising expense will increase in line 
or slightly ahead of sales.


        PART I - FINANCIAL INFORMATION (Continued)
      Item 2.  Management's Discussion and Analysis of
        Results of Operations and Financial Condition
        ---------------------------------------------

                Results of Operations
                ---------------------
      
     Comparison of the Nine Months Ended March 31, 1998
     --------------------------------------------------
       with the Nine Months Ended March 31, 1997
       -----------------------------------------

Basic earnings per share increased 14 percent to $1.93 from $1.69 
and net earnings increased 14 percent to $199,795,000 from 
$175,045,000 a year ago principally due to a 9 percent increase 
in net sales driven by a 9 percent increase in volume.  Strong 
shipment growth was recorded by Clorox 2 and bottled Hidden Valley 
Ranch.  Shipments in our international businesses increased 22 
percent of which approximately half was from base businesses and 
the remainder from acquisitions.  Volume expansion was realized in 
all international markets with the exception of Korea.

Cost of goods sold as a percentage of sales was 43.1 and 44.1 
in the current and year ago periods respectively.  We anticipate 
gross margins for the full year to be slightly favorable 
compared to the prior fiscal year.

Selling, delivery and administration expense increased 11 percent 
due to continued investment in international infrastructure and 
increased investment in information technology.  Advertising 
expense increased over the year ago period.  For the full year 
we anticipate advertising expense will increase in line with or 
slightly ahead of sales.

Interest increased $11,099,000 versus the year ago period 
principally due to additional borrowings to fund the prior year's 
acquisition activity.

Income tax expense as a percent of pretax earnings declined from 
40 percent to 39 percent principally due to an increasing share 
of earnings from International operations located in countries 
with lower statutory tax rates.



         PART I - FINANCIAL INFORMATION (Continued)
       Item 2.  Management's Discussion and Analysis of
         Results of Operations and Financial Condition
         ---------------------------------------------

              Liquidity and Capital Resources
              -------------------------------

The Company's financial position and liquidity remain strong.  
The increase in inventories and accounts receivable reflect 
normal seasonal variations, principally due to the charcoal and 
insecticides business.  The reduction in accounts payable and 
accrued liabilities from June 30, 1997 is due in part to seasonality 
and higher levels of advertising and sales promotion activities 
in our domestic household products businesses recorded at June 30, 
1997.  Increases in commercial paper borrowings and additional 
long-term debt were used to supplement cash provided by operations 
to fund acquisitions and the share repurchase program.

Acquisitions since June 30, 1997 totaled $107,777,000 and were 
financed using a combination of cash provided by operations and 
long-term borrowings. These acquisitions included an additional 
investment in Mexico, the Clorosul bleach business and the Super 
Globo bleach and cleaner businesses in Brazil and two smaller 
acquisitions in Southeast Asia and Australia. 

In September 1996, the Board of Directors authorized a share 
repurchase program to offset the dilutive effect of employee 
stock option exercises.   Based on the Company's experience 
the Company currently expects to issue between 1,200,000 and 
1,500,000 shares of stock each year pursuant to its stock based 
compensation plan, although such numbers may vary.  The 
Company intends to repurchase approximately the same number 
of shares issued over time subject to market conditions and 
business opportunities which may arise.  During the nine month 
period ended March 31, 1998, 440,000 shares at a cost of $34,187,000 
were reacquired.  As part of the repurchase program the 
Company entered into two transactions for the future delivery 
of 400,000 shares of Clorox stock on October 27, 2000 and 
400,000 shares of Clorox stock on October 23, 2002.  The 
aggregate redemption cost is $54,848,000 and the Company 
paid a premium of $13,193,000 on the transaction. 

The Company has approved the use of interest rate derivative 
instruments such as interest rate swaps in order to manage the 
impact of interest rate movements on interest expense.  These 
instruments have the effect of converting fixed rate interest 
to floating, or floating to fixed.  The conditions under which 
derivatives can be used are set forth in a Company Policy 
Statement and include a restriction on the amount of such activity 
to a designated portion of existing debt, a limit on the term of 
any derivative transaction, and a specific prohibition on the 
use of any leveraged derivatives.  In September 1997, the Company 
refinanced $192 million in commercial paper by entering into a 
Sterling denominated financing arrangement with Abbey National 
Bank.  The arrangement has a final maturity of April 2002.  The 
Company entered into a series of swaps with notional amounts 
totaling $192 million to eliminate foreign currency exposure risk 
generated by this Sterling denominated obligation.  The swaps 
effectively convert the Company's 5.7% fixed rate sterling obligation 
to a floating U.S. dollar rate of Libor less 149 basis points or 
4.2% at March 31, 1998.

Management believes the Company has access to additional capital 
through existing lines of credit and from public and private 
sources should the need arise.

The foregoing Management's Discussion and Analysis contains 
"forward-looking" statements under applicable securities laws.  
The Company cautions readers that actual results might differ 
materially from those projected depending on a number of economic 
and competitive risk factors.  For a discussion of such risk 
factors, the Company refers readers to the Company's Form 10-K 
Current Report which was filed on September 25, 1997.






                        S I G N A T U R E
                        -----------------


Pursuant to the requirements of the Securities Exchange Act of 1934, 
the registrant has duly caused this report to be signed on its 
behalf by the undersigned thereunto duly authorized.


                                   THE CLOROX COMPANY
                                   ------------------
                                   (Registrant)




DATE May 8, 1998                    BY /s/HENRY J. SALVO, JR.
     -----------                       ----------------------------
                                        Henry J. Salvo, Jr.
                                        Vice President - Controller